BioMérieux
From Wikipedia, the free encyclopedia
bioMérieux is a worldwide group founded and headquartered in France and listed on the Euronext Paris stock exchange. It is specialized in the field of in vitro diagnostics for medical and industrial sectors. The group designs, develops, and produces a wide range of systems for medicine and industry.
Contents |
[edit] The company
[edit] History
bioMerieux was founded in 1963 by Christophe Merieux's grandfather, Charles. The family Institute Marcel-Merieux was founded in 1897. It is widely considered a pioneer in industrial vaccines.
[edit] Facts and numbers
bioMérieux is present in over 130 countries, with more than 100 distributors and 33 subsidiaries In 2005, the business activity of the company increased by 5.7%, propelling the net sales to 994 million euros and earnings of 90 million euros.
